Drug delivery devices are used for administration of drug compounds in effective ways. A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor hemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more. GlobalData uses proprietary data and analytics to provide a comprehensive report on the central venous catheters devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData


Premium Insights New Zealand Central Venous Catheters Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the central venous catheters market in New Zealand was Becton Dickinson and Co followed by Teleflex, Edwards Lifesciences, B. Braun Melsungen, Vygon and ICU Medical.

Central venous catheters come in different sizes. Antimicrobial, non antimicrobial, and peripherally inserted central venous catheters are included under this category. An antimicrobial central venous catheter is a catheter coated with antimicrobial agents, such as antiseptics or antibiotics. A non antimicrobial central venous catheter does not have any type of antimicrobial coating incorporated into the catheter polymer. A PICC line is a long, thin, soft and flexible catheter (tube) that is inserted through a peripheral vein preferably in the upper arms, and move along until the tip of the tube reaches a large vein above the heart.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the central venous catheters devices market within New Zealand was expected to be over $8m in 2022.

For the latest complete market share analysis of central venous catheters device market in New Zealand, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.